Unraveling the functional contribution of Fkbp5 to stress vulnerability by Pöhlmann, Max


 
 
 
 

 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 


 
 
 
 

Figure 1: The Yerkes-Dodson performance curve - Impact of stress on body 
performance 
Stress causes changes in different body parameters and thereby impacts the 
performance of an individual. Optimal performance requires moderate levels of stress, 
so called eustress. Once it surpasses a critical point, stress can harm the body (distress) 
and lead to a drop in performance and the development of health problems. 
 

Figure 2: The autonomic nervous system 
The ANS consists of two opposing branches, the sympathetic and the parasympathetic 
nervous system. They are activated upon demand and control body functions in the 
periphery.  While the sympathetic system aims to increase activity and alertness by 
redirecting energy resources from organs that are not needed in a specific situation 
(‘fight or flight’ reaction), the parasympathetic system initiates the so called ‘rest and 
digest’ state in which the body is focused on energy production and regeneration.  
Figure 3: The hypothalamic-pituitary-adrenal-Axis 
The HPA-axis is controlling the endocrine reaction to stress by ultimately controlling 
stress hormone levels. Upon stress exposure (1), the paraventricular nucleus (PVN) of the 
hypothalamus initiates the release of CRH (2). Subsequently, CRH causes the pituitary 
gland to release ACTH into the bloodstream (3). Once ACTH reaches the adrenal glands, 
stress hormones (cortisol in humans, corticosterone in rodents) are released into the 
body where they initiate adaptive processes in the periphery (4). The same hormones 
also provide negative feedback to the brain and ultimately cause the whole pathway to 
shut-down after a certain level of saturation is achieved (5). 
 

 
 
Figure 4: Release of stress hormones over time 
Stress hormones like cortisol or corticosterone are not only released in response to a 
stressor but rather follow characteristic release-pattern over the course of a 24h day-
night cycle (simplified depiction). In nocturnal animals like mice, corticosterone levels rise 
during the active, dark phase and are lowest during their inactive phase (left). Exposure 
to stress leads to a quick burst in stress hormone release that can reach different levels 
depending on the time of day (right).   
 


Figure 5: FKBP51 – one of the molecular regulators of the stress response 
Left: Once glucocorticoids reach the brain, they initiate the termination of the stress 
response by binding intracellular GRs. Those receptors are bound to other proteins like 
HSP90 or FKBP51, forming regulative hetero-complexes in the cytosol. FKBP51 is one of 
the major regulators of GR sensitivity. It keeps the GR from entering the nucleus where 
it could act as a transcription factor for genes that are involved in stress response 
termination. Upon binding of a ligand to the GR, FKBP51 is replaced by its close 
homologue FKBP52 which facilitates the translocation of the HSP90-complex into the 
nucleus (most likely via a motor-protein called dynein). Within the nucleus, the GR can 
bind to glucocorticoid-response elements (GRE) and initiate gene transcription. Fkbp5 is 
one of the target genes of the GR, resulting in an ultra-short feedback loop to retain 
protein balance.  
Right: The cytosol contains HSP90-complexes of different compositions (bound to 
FKBP51 or FKBP52 respectively) at all times. Termination of the stress response depends 
on the availability of one or the other variant. Therefore, the balance between the two 
players is a determining factor in this molecular pathway.   
 
 

Figure 6: SAFit2 inhibits FKBP51 functions 
SAFit2 is a modulator, specifically developed to interfere with FKBP51 functionality. Its 
hypothesized mode of action lets it bind to free FKBP51 where it initiates a 
conformational change that prevents FKBP51 from binding to the HSP90-GR-complex. 
Whether it can also target fully assembled complexes is still unknown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Timeline experiment 1 
Experiment 1 was split into two separate cohorts, acute (blue) and chronic (red) stress. 
Each of the two cohorts itself was divided into a control and a stress group respectively. 
Animals from the stress groups were sacrificed at the time-points depicted in this graph 
and tissue was collected for further analysis. 
 
Figure 8: Timeline double in situ hybridization 
A total of 5 animals were sacrificed after a 14 day acclimatization period. Brains were 
cryo-sectioned and used for double ISH.  
5

Figure 9: Timeline experiment 2 
Experiment 2 was divided in 3 subsequent cohorts. Cohort 1 and 2 received an injection 
of Fkbp5 over-expressing AAV into the LC, while cohort 3 received the same injection 
into the DR. All three cohorts were allowed to rest for 31 days after surgery and tested 
as depicted in the timeline. After the last test, animals were sacrificed and tissue was 
collected for further analysis. 
 
Figure 10: Generation of conditional Fkbp5 KO lines 
In order to obtain a genetic KO of Fkbp5 in monoaminergic cell populations, two different 
mouse lines were crossed. Animals with Cre-recombinase linked to either the Nat- or 
Pet-promotor (1) were bred with a line that had exon 9 of the Fkbp5 gene floxed (2). Exon 
9 was cut out by Cre-recombinase in cells containing an active Nat- or Pet-promotors, 
resulting in a dysfunctional FKBP51 protein in these cells (3). 

Figure 11: Timeline experiment 3 
For experiment 3, two lines of conditional Fkbp5 KOs were bred up and tested after a 14 
day acclimatization period. Both lines were tested individually in order to ensure fast 
processing and testing. After the last behavioral test, animals were sacrificed and tissues 
were collected for further analysis. 
 
Figure 12: Timeline experiment 4 
Animals from experiment 4 underwent a quick surgery under anesthesia one day prior 
to the start of the CSDS protocol to implant either empty or SAFit2 loaded pellets 
subcutaneously. In the third week of the CSDS paradigm, animal behavior was tested. 
After the last test, all mice were sacrificed and tissue was collected for further analysis.  
 
Figure 13: Timeline experiment 5 
In experiment 5, animals were assigned to four different groups. Depending on their 
group, animals received an injection of empty or SAFit2 loaded VPG. After one day of 
recovery, animals were tested for behavior. On each consecutive day, half of each group 
received a vehicle injection while the other half was injected with Escitalopram 30 
minutes prior to the start of testing. After the last behavioral test, animals were sacrificed 
and tissues were collected for future analysis.  
 
Figure 14: Timeline experiment 6 
At the start of experiment 6, animals received either an s.c. injection of dissolved SAFit2 
in a fluid solution, or an injection of VPG, loaded with 30% or 50% SAFit2. Blood samples 
were obtained at the indicated time-points and blood plasma was extracted for analysis 
of SAFit2 content. 
 
Figure 15: Timeline experiment 7 
Animals from the pharmacology group were treated with either empty or SAFit2 loaded 
VPG 4 days prior to the experiment. At test day, animals were recorded in their home 
setting for 15 minutes. After the baseline recording, they were restrained in 50ml falcon 
tubes for 15 minutes before they were allowed to return to their home cage, in which 
they were video-taped for another 15 minutes. Following the last session, animals were 
sacrificed and tissue was collected for future analysis. 
 
 
Figure 16: Social defeat stress - Male aggressiveness towards intruders as a severe 
stressor for experimental mice 
Specimen of a physically superior, more aggressive strain (CD1) compared to the 
experimental animals (C57Bl/6n background) were trained to defend their home cage 
against intruders. Once an experimental mouse was introduced, they were allowed to 
attack for up to 3 minutes, depending on severity of the defeat (right). The animals were 
separated before any serious injuries could occur. 
 
 
 
 
 
 
 
Figure 17: Injection methods 
Left: For i.p. injections, animals were restrained and held in a supine position with its head 
lower than the body. The injection was aimed to the lower quadrant of the abdomen at 
a slight angle of approximately 10°. The needle was inserted through the abdominal wall 
without puncturing any underlying organs. 
Right: Animals are carefully restrained in order to prevent sudden movement. Then the 
needle is inserted into the skin fold in the neck area. 
 
 
 
Table 1: Overview retention time and transitions 
This table shows the different retention time and transitions monitored during the analysis 
of the SAFit2 probes 
 
Compound Used as Q1_Mass Q3_Mass 
RT 
[min] 
DP 
[V] 
EP 
[V] 
CE 
[V] 
CXP 
[V] 
SAFit2 Quantifier 803.2 384.2 4.95 141 10 41 18 
SAFit2 Qualifier 803.2 114.2 4.95 141 10 67 8 
SAFit2-D3 Internal Standard 806.4 384.3 4.95 106 10 41 26 
 
 
 
 
 
Figure 18: The open field test 
In the OF, animals were allowed to freely explore a square arena, made from gray PVC. 
Factors of interest are the distance covered and the time, mice spend in the more aversive 
central area of the box. 
 
Figure 19: The object recognition test 
The ORT consists of (several) acquisition phases in which the animals are allowed to 
familiarize themselves with two identical objects and a retrieval phase. During the 
retrieval phase, one of the objects is replaced by an unfamiliar one. The animals’ ability 
to discriminate between the objects and remember the familiar one is determined by the 
times they investigate either object. 
 
Figure 20: The object relocation test 
Similar to the ORT, this test consists of (several) acquisition phases and a retrieval trial. 
During the acquisition, animals can freely explore the arena that contains two identical 
objects. During the retrieval, one of the objects is moved to a different location within 
the box. Interaction times are measured in order to determine the animals’ capacity to 
recall the original placement of the objects. 
 
Figure 21: The dark-light box test 
The DaLi is a test for anxiety-like behavior. The arena consists of two compounds, 
connected by a tunnel. While the bigger side of the box is brightly illuminated (and 
therefore aversive for nocturnal animals) the smaller compartment is dark. Levels of 
anxiety-like behavior can be determined based on the time animals spend in each of the 
two compartments and the latency until they first enter the aversive side. 
 
Figure 22: The elevated plus maze test 
Similar to the DaLi, the EPM is considered a classical test for anxiety-like behavior. The 
plus-shaped arena is elevated to a height that generally prevents animals from jumping 
off. While two opposing arms are surrounded by a wall to all sided (and therefore 
considered safe), the two remaining arms are open and  
 
Figure 23: The social avoidance test 
The SA test consists of two short trials. In the first trial, a small empty cage is placed in 
the test arena. The experimental animal is then allowed to explore the setup and the 
interaction time with the cage is measured. In the second trial, a social cue (juvenile 
mouse of the same sex but a different strain) is placed in the cage and the interaction 
time is assessed again. Mice that show higher interaction times with the social compared 
to the non-social cue are considered ‘social’ animals.  
 
Figure 24: The forced swim test 
The FST was used as a stressor, as well as a test to determine stress coping behavior. 
Animals were placed in a beaker filled with water and their behavior was filmed. As mice 
are quite accomplished swimmers, they show three different types of behavior: struggling, 
swimming and floating. The amount of time spent executing each behavior was used to 
determine their ability to cope with the stressful situation. 
 
 
Figure 25: The Y-maze test 
The arena for the Y-maze consists of three arms connected by a central area. In the first 
trial, the animals were allowed to explore two of the arms while one of them was blocked. 
In the second trial all arms were open to explore and the animals’ ability to recognize 
and memorize the familiar arms was measured. 
 
 
 
 
 
 
 
Table 2: Genotyping of genetically modified mouse lines – Primers and details 
The table lists all used primers and the PCR conditions for the genotyping of conditional 
and conventional Fkbp5 KOs. 
  
Fkbp5KO 
Primer Sequence 
51Ex2-fw 5'AAAGGACAATGACTACTGATGAGG3' 
51Int2/3-re 5'AAGGAGGGGTTCTTTTGAGG3' 
B-gal-rev2 5'GTTGCACCACAGATGAAACG3' 
PCR product PCR condition 
363bp (WT); 510-550bp (KO) 95°C 4min [35x (95°C 30s, 55°C 30s, 72°C 40s)] 72°C 5 min, 4°C ∞ 
lox/lox 
Primer Sequence 
Fkbp5-GT-1-c : 5'-ACTATCTCACAAGCCGTCCA-3' 
Fkbp5-GT-2-nc: 5'ATGAAGGTCACGTGCTCAGG-3' 
Fkpb5-GT-Flp-nc 5`-AATAAAGCCTAGGACCCGCC-3´ 
PCR product PCR condition 
249bp (WT); 504bp (Mutant) 95°C 5min [35x (95°C 30s, 61°C 30s, 72°C 1:30min)] 72°C 5 min, 4°C ∞ 
Cre-recombinase 
Primer Sequence 
Cre R 5´-AATCGCCATCTTCCAGCAG-3´ 
Cre F 5´-GATCGCTGCCAGGATATACG-3´ 
Thy-R 5´-CCACTGGTGAGGTTGAGG-3´ 
Thy-F 5´-TCTGAGTGGCAAAGGACCTTAGG-3´ 
PCR product PCR condition 
372bp (Thy control band) 
574bp (Cre band) 
95°C 5min [35x (95°C 15s, 57°C 30sek, 72°C 1min)] 72°C 5 min, 4°C ∞ 
 
 
 
 
Figure 26: Fkbp5 mRNA expression after exposure to acute stress 
Animals from the stress group (ASDS) did show higher Fkbp5 mRNA expression levels 
than unstressed controls in all selected brain areas (A, C-G), except the CA2 region of the 
hippocampus (B). Data are represented as mean ± SEM. * significantly different from the 
control condition. 
 
Figure 27: Fkbp5 mRNA expression after exposure to chronic stress 
Fkbp5 mRNA expression was not altered in any of the selected regions after a three week 
exposure to CSDS (A-G). Data are represented as mean ± SEM.  
Figure 28: Organ weight after CSDS 
Adrenal glands (A) were significantly enlarged while the size of the thymus (B) was 
decreased in stressed animals. Data are represented as mean ± SEM. * significantly 
different from the control condition. 
 
 
Figure 29: Co-localization of Fkbp5 and Th in the locus coeruleus 
Fkbp5 (silver grains) and Th (red staining) expression pattern determined by dISH. Double 
positive neurons were observed in the LC (exemplary indication by black arrows).  
Figure 30: Co-localization of Fkbp5 and Sert in the dorsal raphe nucleus 
Fkbp5 (silver grains) and Sert (red staining) expression pattern determined by dISH. 
Overlap of both stainings indicates double positive neurons in the DR (exemplary 
indication by black arrows). 
 
Figure 31: AAV-injections into the locus coeruleus 
This figure shows the estimated center-point of each successful injection. Individuals that 
did not show expression in the targeted areas were excluded from the analysis. 
Figure 32: Open field test results (experiment 2, cohort 1)  
OE of Fkbp5 in the LC did reduce the distance traveled (A) without significantly affecting 
immobility (B). Animals of the LC Fkbp5-OE group did spend more time in the aversive 
inner zone during the first 5 minutes of the test (D), however, overall time in the center 
was not altered (C). Data are represented as mean ± SEM. * significantly different from 
the control condition. 
Figure 33: Elevated plus maze test results (experiment 2, cohort 1) 
Neither the latency until animals entered the open arm for the first time (A), nor the total 
open arm time (B) was affected by OE of Fkbp5 in the LC. Data are represented as mean 
± SEM.  
Figure 34: Dark-light box test results (experiment 2, cohort 1) 
Neither the latency until animals entered the lit zone for the first time (A), nor the time 
in the lit zone (B) was affected by OE of Fkbp5 in the LC. Data are represented as mean 
± SEM.  
Figure 35: Forced-swim test results (experiment 2, cohort 1) 
Fkbp5 OE in the LC did not affect struggling (A), swimming (B) or floating (C) behavior. 
Data are represented as mean ± SEM.  
Figure 36: Bodyweight over time (experiment 2, cohort 1) 
Bodyweight did not differ between the two groups. All animals increased in weight due 
to their growth over the 63 day testing period. Data are represented as mean ± SEM. 
Figure 37: Organ weight (experiment 2, cohort 1) 
Adrenal glands (A) were significantly enlarged while thymi (B) did not differ in weight 
between the controls and the LC Fkbp5-OE animals. Data are represented as mean ± 
SEM. * significantly different from the control condition. 
 
Figure 38: AAV-injections into the locus coeruleus 
This figure shows the estimated center-point of each successful injection. Individuals that 
did not show expression in the targeted areas were excluded from the analysis. 
Figure 39: Open field test results (experiment 2, cohort 2) 
In cohort 2, the OF test was repeated three times. There was no difference in distance 
traveled in the first two tests, however, OE animals showed a decrease in distance 
traveled (A) and an increase in immobility (B) during the third OF. The time they spent 
exploring the inner zone of the arena was significantly different in the second test with 
OE animals showing a decrease (C). Data are represented as mean ± SEM. * significantly 
different from the control condition. 
Figure 40: Y-maze test results (experiment 2, cohort 2) 
Animals from both groups showed intact memory, indicated by their ability to recognize 
the novel arm of the maze. There was no treatment effect between the groups. Data are 
represented as mean ± SEM. § significantly different from chance level. 
Figure 41: Object relocation test results (experiment 2, cohort 2) 
None of the two groups did show a significant preference for the object in the novel 
location. Data are represented as mean ± SEM.  
Figure 42: Social avoidance test 1 results (experiment 2, cohort 2) 
Animals that OE Fkbp5 in the LC did show lower interaction times in trial 1 (A) and trial 2 
(B). Both groups did show a preference for the social cue compared to the non-social 
cue but there was no difference between controls and OE animals (C). Data are 
represented as mean ± SEM. * significantly different from the control condition. § 
significantly different from chance level. 
Figure 43: Social avoidance test 2 results (experiment 2, cohort 2) 
During the second SA, animals of the LC Fkbp5-OE group did interact significantly less 
with the non-social cue than controls (A). There was no difference in the second trial (B). 
Both groups showed a loss of social preference after the subthreshold defeat, without 
revealing any differences between them (C). Data are represented as mean ± SEM. * 
significantly different from the control condition. 
Figure 44: Forced swim test 1 results (experiment 2, cohort 2) 
There was no difference between the two groups in struggling (A), swimming (B) or 
floating behavior (C). Data are represented as mean ± SEM.  
Figure 45: Forced swim test 2 results (experiment 2, cohort 2) 
Treatment with Escitalopram had no effect on behavior in the second FST. Data are 
represented as mean ± SEM.  
Figure 46: Endocrinology (experiment 2, cohort 2) 
Over-expression of Fkbp5 in the LC did not affect baseline corticosterone levels (A). The 
stress response (B) and recovery rate (C) remained unchanged as well. Data are 
represented as mean ± SEM.  
 
Figure 47: AAV-injections into the dorsal raphe nucleus 
This figure shows the estimated center-point of each successful injection. Individuals that 
did not show expression in the targeted areas were excluded from the analysis. 
Figure 48: Open field test results (experiment 2, cohort 3) 
Neither the traveled distance (A), nor immobility (B) or the time animals spent in the inner 
zone of the arena (C) were affected by the OE of Fkbp5 in the DR. Data are represented 
as mean ± SEM.  
Figure 49: Elevated plus maze results (experiment 2, cohort 3) 
There was no detectable difference between the two groups in latency to the first entry 
into an open arm (A) or the total time spent in the aversive area of the maze (B). Data are 
represented as mean ± SEM.  
Figure 50: Dark-light box test results (experiment 2, cohort 3) 
There was no significant difference between the two groups in latency to the first entry 
into the lit zone (A) or the total time spent in the aversive area of the arena (B). Data are 
represented as mean ± SEM.  
Figure 51: Social avoidance test 1 results (experiment 2, cohort 3) 
Interaction times with the cues did not differ between the groups in trial 1 (A) or trial 2 
(B). Both groups failed to prefer the social cue over the non-social one (C). Data are 
represented as mean ± SEM.  
Figure 52: Social avoidance test 2 results (experiment 2, cohort 3) 
Both groups showed similar interaction times with the cues in trial 1 (A) and trial 2 (B). 
Subthreshold defeat induced active avoidance of the social cue in both groups (C). Data 
are represented as mean ± SEM. § significantly different from the control condition. 
Figure 53: Object relocation test results (experiment 2, cohort 3) 
Control animals were able to discriminate between the objects in the familiar and the 
novel location, demonstrated by the preference for the unfamiliar one. Animals over-
expressing Fkbp5 in the DR did not show any discrimination between the objects in the 
retrieval phase. Data are represented as mean ± SEM. § significantly different from the 
control condition. 
Figure 54: Forced swim test 1 results (experiment 2, cohort 3) 
There was no detectable difference between struggling (A), swimming (B) or floating (C) 
times between the groups in the first FST. Data are represented as mean ± SEM. 
Figure 55: Forced swim test 2 results (experiment 2, cohort 3) 
Treatment with Escitalopram did increase struggling behavior (#), while OE had no effect 
(A). Swimming behavior was not affected by Escitalopram treatment or the OE (B). 
Floating was reduced by Escitalopram (C). Data are represented as mean ± SEM. # 
significant Escitalopram main effect. 
Figure 56: Bodyweight over time  (experiment 2, cohort 3) 
There was no difference in bodyweight between control and OE animals. Data are 
represented as mean ± SEM.  
Figure 57: Endocrinology (experiment 2, cohort 3) 
No difference in baseline corticosterone levels was present between controls and OE 
animals (A). While the stress response was also not changed (B), OE animals recovered 
quicker 90 minutes after stress (C). Data are represented as mean ± SEM. * significantly 
different from the control condition. 
 
 
Figure 58: Conditional knock-out of Fkbp5 in the locus coeruleus 
The conditional KO of Fkbp5 in the LC was confirmed by ISH. Red circles indicate the 
location of the LC in Fkbp5LC WT (1) and Fkbp5LC KO (2) animals. 
Figure 59: Open field test results (experiment 3, Nat- Cre) 
Conditional KO of Fkbp5 in the LC did not affect locomotor behavior in three consecutive 
OF tests. Both groups showed the same amount of distance traveled (A), similar levels of 
immobility (B) and no difference in the time they spent in the aversive mid-section of the 
arena (C). Data are represented as mean ± SEM.  
Figure 60: Object relocation test results (experiment 3, Nat- Cre) 
Both, WTs and KOs were able to memorize the positions of the objects and spent more 
time investigating the one in the unfamiliar location. Animals from the KO group however 
did show significantly lower levels of recognition. Data are represented as mean ± SEM. 
* significantly different from the WT control condition. § significantly different from 
chance level. 
Figure 61: Dark-light box test results (experiment 3, Nat-Cre) 
There was no difference between controls and KOs in terms of the time between the start 
of the test and their first entry into the lit compartment of the arena (A). KOs did spend 
significantly less time in the lit zone compared to WT controls (B). Data are represented 
as mean ± SEM. * significantly different from the WT control condition. 
Figure 62: Elevated plus maze test results (experiment 3, Nat-Cre) 
There was no difference between conditional KOs and WT controls  when looking at the 
latency to their first entry into to open arms (A) or the time they spent on the aversive, 
open sections of the maze (B). Data are represented as mean ± SEM. 
Figure 63: Social avoidance test 1 results (experiment 3, Nat-Cre) 
Both groups spent similar times interacting with the non-social and the social cue in trial 
1 (A) and trial (2). When both trials were compared, WT controls did show social 
preference while KOs did no show preference for any of the cues (C). Data are 
represented as mean ± SEM. § significantly different from chance level. 
Figure 64: Social avoidance test 2 results (experiment 3, Nat-Cre) 
Similar to the first SA, there was no difference between the groups in time spent with any 
of the two cues during both trials (A, B). When considering the discrimination index, WT 
controls lost their social preference after the subthreshold defeat and showed no 
preference for any of the cues. Data are represented as mean ± SEM.  
Figure 65: Social avoidance test 2 split (experiment 3, Nat-Cre) 
This graph shows the same data as Figure 64, however split into susceptible and resilient 
animals based on their discrimination index in SA1 (A) and SA2 (B). While KO animals 
remain at a similar level after the subthreshold defeat, WT controls that were susceptible 
in SA1 showed less interaction during SA2. Data are represented as mean ± SEM. 
Figure 66: Forced swim test results (experiment 3, Nat-Cre) 
There was no genotype effect on struggling (A), swimming (B) or floating behavior (C). 
Data are represented as mean ± SEM.  
Figure 67: Bodyweight (experiment 3, Nat-Cre) 
There was no difference in bodyweight between WT controls and conditional KOs. Data 
are represented as mean ± SEM. 
Figure 68: Organs (experiment 3, Nat-Cre) 
Genotype did not affect the relative weight of the adrenal glands (A) or the thymus of 
the animals (B). Data are represented as mean ± SEM.  
Figure 69: Endocrinology (experiment 3, Nat-Cre) 
Corticosterone levels were not affected by genotype neither under baseline conditions 
(A), nor in response to stress (B) or in the recovery rate after the stressor (C). Data are 
represented as mean ± SEM. 
 
Figure 70: Conditional knock-out of Fkbp5 in the dorsal raphe nucleus 
The conditional KO of Fkbp5 in the DR was confirmed by ISH. Red circles indicate the 
location of the LC in Fkbp5DR WT (1) and Fkbp5DR KO (2) animals. 
 
Figure 71: Open field test results (experiment 3, Pet-Cre) 
There was no difference in behavior in the first of three OF tests. However, conditional 
KOs failed to adapt to the test setup and stayed more active in the second and third OF, 
indicated by higher levels of distance traveled (A) and lower immobility (B) when 
compared to WT controls. The time in the inner zone was not affected by genotype (C). 
Data are represented as mean ± SEM. * significantly different from the WT control 
condition. 
Figure 72: Object relocation test results (experiment 3, Pet-Cre) 
Both genotypes were able to discriminate between the object in the familiar and the one 
in the novel location, indicated by the preference for the latter. There was no difference 
between the two genotypes however. Data are represented as mean ± SEM. § 
significantly different from chance level. 
Figure 73: Object recognition test results (experiment 3, Pet-Cre) 
Similar to the OLT, animals of both genotypes showed a preference for the novel object. 
Again, there was no difference between the groups. Data are represented as mean ± 
SEM. § significantly different from chance level. 
Figure 74: Dark-light box test results (experiment 3, Pet-Cre) 
No differences in the latency to the first entry into the lit zone (A) or the overall time 
spent in the lit zone (B) were observed. Data are represented as mean ± SEM. 
Figure 75: Elevated plus maze test results (experiment 3, Pet-Cre) 
There was no difference in the latency to first open arm entry (A) or the time they spent 
on the open arms of the arena (B). Data are represented as mean ± SEM. 
Figure 76: Social avoidance test 1 results (experiment 3, Pet-Cre) 
Both groups showed similar levels of interaction with the non-social cue (A) and the 
social cue (B). Neither of the two genotypes showed preference for the social cue 
compared to the non-social one. Data are represented as mean ± SEM.  
Figure 77: Social avoidance test 2 results (experiment 3, Pet-Cre) 
Both groups showed similar levels of interaction with the non-social cue (A) and the 
social cue (B). After the subthreshold defeat, neither of the two genotypes showed 
preference for the social cue compared to the non-social one. Data are represented as 
mean ± SEM.  
Figure 78: Forced swim test results (experiment 3, Pet-Cre) 
There was no difference between genotypes in struggling (A), swimming (B) or floating 
(C) times in the FST. Data are represented as mean ± SEM.  
Figure 79: Bodyweight (experiment 3, Pet-Cre) 
Conditional KOs were significantly heavier than WT controls. Data are represented as 
mean ± SEM. * significantly different from the WT control condition. 
Figure 80: Organs  (experiment 3, Pet-Cre)  
Genotype did not affect the relative weight of the adrenal glands (A) or the thymus of 
the animals (B). Data are represented as mean ± SEM.  
Figure 81: Endocrinology  (experiment 3, Pet-Cre) 
Corticosterone levels were not affected by genotype neither under baseline conditions 
(A), nor in response to stress (B) or in the recovery rate after the stressor (C). Data are 
represented as mean ± SEM.  
 
 
Figure 82: Blood plasma levels of SAFit2 after chronic treatment via slow-releasing 
subcutaneous pellets (experiment 4) 
SAFit2 levels remained stable in all four groups over the course of the 21 day experiment. 
There was no difference in SAFit2 plasma concentration between the groups. Data are 
represented as mean ± SEM.  
 
Figure 83: Open field test results (experiment 4) 
Chronically stressed animals did cover less distance (A) and showed increased immobility 
(B) during the OF test when compared to unstressed controls. They spent less time in the 
aversive center zone of the maze (C), indicating higher levels of anxiety and reduced 
explorative behavior. SAFit2 treatment did not affect behavior in this test. Data are 
represented as mean ± SEM. # significant main stress effect. 
 
Figure 84: Elevated plus maze test results (experiment 4) 
There was a significant stress effect in both, the latency to the first entry into the open 
arms (A) and the overall time, animals spent exploring the open arms (B). SAFit2 
treatment had no effect on anxiety-like behavior in the EPM. Data are represented as 
mean ± SEM. # significant main stress effect. 
 
Figure 85: Dark-light box test results (experiment 4) 
There was an overall stress effect on behavior in the DaLi. Animals from the CSDS group 
did enter the lit zone later than unstressed controls (A) and did spend less time in the lit 
compartment (B). SAFit2 treatment had no effect on behavior in the DaLi. Data are 
represented as mean ± SEM. # significant main stress effect. 
 
Figure 86: Social avoidance test results (experiment 4) 
All 4 groups showed similar levels of interest in the non-social cue during trial 1 (A). In 
trial 2, stressed animals interacted significantly less with the cue when compared to non-
stressed controls (B). SAFit2 had no effect on interaction times with the cues. Unstressed 
animals of both treatment groups did show social preference, while stressed mice did 
not prefer the social over the non-social cue (C). SAFit2 treatment did result in a trend 
towards social preference, but the effect was not significant. Data are represented as 
mean ± SEM. § significantly different from chance level. # significant main stress effect. 
 
 
Figure 87: Forced swim test results (experiment 4) 
Struggling (A) and swimming behavior (B) was not affected by stress or SAFit2 treatment. 
Stress exposure did increase the time animals spent floating when compared to 
unstressed controls (C). However, SAFit2 had no effect on floating behavior in the FST. 
Data are represented as mean ± SEM. # significant main stress effect. 
 
Figure 88: Organs (experiment 4) 
Stress did induce a very robust effect on the size of endocrine organs. Relative adrenal 
weights of stressed animals were significantly increased (A) while the thymi were smaller, 
compared to unstressed controls (B). SAFit2 treatment did not affect organ weight. Data 
are represented as mean ± SEM. # significant main stress effect. 
 
 
Figure 89: Open field test results  (experiment 5) 
Escitalopram did increase the distance traveled in the OF and co-medication with SAFit2 
did result in an interaction effect for this parameter (A). Immobility was also reduced by 
Escitalopram application (B). There was a significant effect of Escitalopram as, well as an 
Escitalopram x SAFit2 interaction effect on the time, animals spent in the aversive inner 
zone of the arena (C). Data are represented as mean ± SEM. # significant main stress 
effect. # significant Escitalopram main effect. + significant interaction effect. 
Figure 90: Open field test results  (experiment 5, 5 minute time segments) 
In order to better analyze locomotion in the OF, this graph shows behavior in each of the 
three 5-minute time segments of the test. Distance traveled was higher in Escitalopram 
treated animals in general, however, after the first 5 minutes of the test, combination 
with SAFit2 results in a significantly faster drop in activity (A). Immobility on the other 
hand was solely affected by Escitalopram with no changes induced by SAFit2 application 
(B). Even though there was a significant interaction effect on inner zone time in regard 
of the whole 15 minute test, there were no differences in one of the three segments when 
tested individually (C). Data are represented as mean ± SEM. # significant Escitalopram 
main effect. * significant SAFit2 main effect. 
 
Figure 91: Elevated plus maze test results  (experiment 5) 
SAFit2 as well as Escitalopram treatment resulted in significant main effects when 
regarding the distance, animals traveled on the EPM (A). In addition, SAFit2 significantly 
hampered the effect of Escitalopram when applied together. Open arm entries were only 
affected by Escitalopram with no SAFit2 effect (B). The same was true for the time the 
mice spent on the open arms of the arena (C). Data are represented as mean ± SEM. $ 
significant SAFit2 effect. # significant Escitalopram main effect. * significant SAFit2 main 
effect. 
 
Figure 92: Dark-light box test results  (experiment 5) 
There was a significant interaction effect for the time animals spent in the more aversive 
lit zone of the arena. Data are represented as mean ± SEM. + significant interaction effect. 
 
Figure 93: Forced swim test results  (experiment 5) 
Struggling behavior in the FST was increased by both, Escitalopram as well as SAFit2 
application. This effect was mainly driven by the drastic increase in struggling when both 
drugs were injected together (A). The amount of swimming was only affected by 
Escitalopram with no effects caused by SAFit2 treatment (B). Floating behavior was 
significantly changed after both, SAFit2 as well as Escitalopram treatment. Notably, the 
Escitalopram effect could be mainly driven by the SAFit2 group and might not be 
biologically relevant (C). Data are represented as mean ± SEM. # significant Escitalopram 
main effect. * significant SAFit2 main effect. + significant interaction effect. 
 
Figure 94: Effects on hypothalamic-pituitary-adrenal-axis function 
(A) Basal corticosterone secretion is unaffected by SAFit2 or escitalopram 
treatment. (B) SAFit2 reduces corticosterone secretion in response to an acute stressor 
in vehicle treated animals, while no effect is observed under Escitalopram 
treatment. (C) Ninety minutes after the onset of the stressor (recovery), SAFit2 
suppression of the HPA axis function is observed in both vehicle and Escitalopram-
treated animals, but only reaches post hoc significance in the Escitalopram-treated 
group. Data are represented as mean ± SEM. * significant SAFit2 effect. § significant 
SAFit2 main effect. + significant interaction effect. 
 
 
 
Figure 95: SAFit2 concentrations in blood plasma  (experiment 6) 
Injection with SAFit2 solution did result in a massive spike of the drug in the blood 
plasma. However, levels dropped relatively quickly over the course of 96 hours (A). Using 
SAFit2 loaded VPGs on the other hand evoked lower total levels of SAFit2 in the plasma 
initially, however levels stayed at a comparatively high level for up to 14 days post 
injection (B). 
 
 
 
Figure 96: Home cage behavior – walking (experiment 7) 
When looking at home cage behavior pre and post stress, the time animals from cohort 
1 spent walking was significantly reduced by the exposure to a stressor (A). In cohort 2, 
there was a significant main effect for stress, as well as a significant treatment x stress 
interaction (B). Data are represented as mean ± SEM. # significant stress main effect. + 
significant interaction effect. 
Figure 97: Home cage behavior – rearing (experiment 7) 
Rearing behavior was significantly reduced by stress in both genotypes of cohort 1 (A). 
SAFit2 treated animals showed reduced levels of rearing when compared to controls that 
received a vehicle injection, both pre and post stress. Restraining the mice did reduce 
rearing behavior in both groups of cohort 2 (B). Data are represented as mean ± SEM. # 
significant stress main effect. * significant genotype/treatment main effect.  
Figure 98: Home cage behavior – climbing (experiment 7) 
Climbing behavior was significantly reduced by stress in both genotypes of cohort 1 (A). 
SAFit2 injected animals showed reduced levels of rearing when compared to controls 
treated with vehicle, both pre and post stress. Restraining the animals did reduce rearing 
behavior in both groups of cohort 2 (B). Data are represented as mean ± SEM. # 
significant stress main effect. * significant genotype/treatment main effect. 
 
Figure 99: Home cage behavior – surveying (experiment 7) 
Surveying behavior in the home cage was neither impacted by genotype in cohort 1 (A), 
nor affected by SAFit2 treatment in cohort 2 (B). However, stress increased the amount 
of surveying behavior in both cohorts. Data are represented as mean ± SEM. # significant 
stress main effect.  
Figure 100: Home cage behavior – grooming (experiment 7) 
Grooming behavior in the home cage was not impacted by genotype in cohort 1 (A). 
SAFit2 treatment in cohort 2 reduced the amount of grooming overall, however this 
effect is mainly driven by a reduction following the 15 minute stress-period (B). Stress 
significantly increased the amount of grooming behavior in both cohorts. Data are 
represented as mean ± SEM. # significant stress main effect. * significant 
genotype/treatment main effect.  
Figure 101: Home cage behavior – digging (experiment 7) 
Stress did reduce digging behavior in cohort 1 (A). There was no effect of genotype. 
Digging was neither affected by stress, nor by treatment with SAFit2 in cohort 2 (B). Data 
are represented as mean ± SEM. # significant stress main effect. 
 
 


Figure 102: Hypothetical  impact of chronic stress on corticosterone release 
This figure depicts two hypothetical ways chronic stress could impact the circadian 
rhythm of corticosterone release. One possibility is a general elevation (red arrows) of 
baseline glucocorticoid levels triggered by chronic activation of the HPA-axis (left). In 
that case an acute stressor (shaded in red) would cause a spike of corticosterone release 
on top of already increased baseline levels. The second option (right) is characterized by 
normal corticosterone levels over the course of 24 hours, however sensitivity of the 
hormonal reaction is increased in case of a stressful event (red arrows). Black arrows 
indicate the time of sacrifice in experiment 1. 
 
Figure 103: Connectivity of the monoaminergic system 
Both monoaminergic nuclei, the LC and the DR, are interconnected with a number of 
different regions all over the brain. This figure depicts a selection of areas that are 
innervated by either noradrenergic neurons originating from the LC (red) or serotonergic 
neurons controlled by the DR (blue). Adapted from (Lee and Han, 2019) 
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